INM Chart
About

InMed Pharmaceuticals Inc., a clinical stage pharmaceutical company, develops a pipeline of prescription-based products in the United States. The company operates through two segments, InMed Pharmaceuticals and BayMedica Commercial. The InMed Pharmaceuticals segment researches and develops cannabinoid-based pharmaceuticals products. The BayMedica Commercial segment develops proprietary manufacturing technologies to produce and sell rare cannabinoids for the health and wellness industry. Its prescription-based products include rare cannabinoids and novel cannabinoid analogs for the treatment of diseases with unmet medical needs. The company's lead product consists of INM-755, a cannabinol topical skin cream that has completed Phase 2 clinical trial for the treatment of epidermolysis bullosa. It also develops INM-089, a small molecule compound that acts as a selective dual CB1/CB2 agonist; and INM-900 for neurodegenerative diseases, as well as INM-901, a small molecule for treatment of Alzheimer's disease. In addition, the company offers IntegraSyn, an integrated biosynthesis-based manufacturing approach for pharmaceutical-grade cannabinoids; and cannabichromene, cannabicitran, cannabidivarin, and tetrahydrocannabivarin. The company was formerly known as Cannabis Technologies Inc. and changed its name to InMed Pharmaceuticals Inc. in October 2014. InMed Pharmaceuticals Inc. was incorporated in 1981 and is headquartered in Vancouver, Canada.

Fundamentals
Scroll to Statements
Sector Healthcare Industry Drug Manufacturers - Spe Market Cap 2.57M
Enterprise Value -3.90M Income -7.66M Sales 4.51M
Book/sh 3.42 Cash/sh 2.40 Dividend Yield —
Payout 0.00% Employees 13 IPO —
P/E — Forward P/E -0.14 PEG —
P/S 0.57 P/B 0.26 P/C —
EV/EBITDA 0.51 EV/Sales -0.86 Quick Ratio 4.85
Current Ratio 5.94 Debt/Eq 5.55 LT Debt/Eq —
EPS (ttm) -6.09 EPS next Y -6.25 EPS Growth —
Revenue Growth -26.20% Earnings 2026-05-12 ROA -49.77%
ROE -97.20% ROIC — Gross Margin 29.73%
Oper. Margin -258.57% Profit Margin -170.07% Shs Outstand 2.92M
Shs Float 2.09M Short Float 5.94% Short Ratio 1.91
Short Interest — 52W High 7.98 52W Low 0.85
Beta 0.40 Avg Volume 111.93K Volume 55.62K
Target Price — Recom None Prev Close $0.85
Price $0.88 Change 3.53%
Valuation Models

Price estimates from analyst targets and simple models.

1. Analyst consensus
—
Mean price target
2. Current target
$0.88
Latest analyst target
3. DCF / Fair value
$-26.55
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$0.88
Low
—
High
—
Mean
—
Insider Transactions
Date Shares Value Url Text Insider Position Transaction Start Date Ownership
0 240 42 — Sale at price 0.18 per share. MANCINI ALEXANDRA DIANE JANET Unknown — 2024-07-31 00:00:00 D
Financials
Line Item2025-06-302024-06-302023-06-302022-06-30
TaxEffectOfUnusualItems0.00-9.29K-19.27K0.00
TaxRateForCalcs0.000.150.400.00
NormalizedEBITDA-7.23M-7.00M-7.73M-8.38M
TotalUnusualItems-28.47K-61.92K-48.17K-4.90M
TotalUnusualItemsExcludingGoodwill-28.47K-61.92K-48.17K-4.90M
NetIncomeFromContinuingOperationNetMinorityInterest-8.16M-7.68M-7.95M-18.60M
ReconciledDepreciation534.73K604.52K596.00K511.79K
ReconciledCostOfRevenue2.91M3.11M2.34M219.76K
EBITDA-7.26M-7.06M-7.78M-13.28M
EBIT-7.79M-7.67M-8.38M-13.79M
NetInterestIncome-215.67K527.90K492.44K96.09K
InterestExpense371.55K0.000.00360.35K
InterestIncome155.88K527.90K492.44K96.09K
NormalizedIncome-8.13M-7.62M-7.92M-13.70M
NetIncomeFromContinuingAndDiscontinuedOperation-8.16M-7.68M-7.95M-18.60M
TotalExpenses12.86M12.73M12.51M14.88M
DilutedAverageShares975.99K381.05K122.42K28.04K
BasicAverageShares975.99K381.05K122.42K28.04K
DilutedEPS-8.36-20.20-65.00-663.40
BasicEPS-8.36-20.20-65.00-663.40
DilutedNIAvailtoComStockholders-8.16M-7.68M-7.95M-18.60M
NetIncomeCommonStockholders-8.16M-7.68M-7.95M-18.60M
NetIncome-8.16M-7.68M-7.95M-18.60M
NetIncomeIncludingNoncontrollingInterests-8.16M-7.68M-7.95M-18.60M
NetIncomeContinuousOperations-8.16M-7.68M-7.95M-18.60M
TaxProvision0.007.10K13.10K0.00
PretaxIncome-8.16M-7.67M-7.93M-18.60M
OtherIncomeExpense-28.47K-61.92K-48.17K-4.90M
SpecialIncomeCharges0.00-3.47M0.00
ImpairmentOfCapitalAssets0.003.47M0.00
GainOnSaleOfSecurity-28.47K-61.92K-48.17K-1.43M
NetNonOperatingInterestIncomeExpense-215.67K527.90K492.44K96.09K
InterestExpenseNonOperating371.55K0.000.00360.35K
InterestIncomeNonOperating155.88K527.90K492.44K96.09K
OperatingIncome-7.92M-8.13M-8.38M-13.79M
OperatingExpense9.62M9.24M9.78M14.34M
DepreciationAmortizationDepletionIncomeStatement212.84K219.60K202.25K185.66K
DepreciationAndAmortizationInIncomeStatement212.84K219.60K202.25K185.66K
ResearchAndDevelopment2.85M3.22M3.73M7.28M
SellingGeneralAndAdministration6.56M5.80M5.85M6.87M
GeneralAndAdministrativeExpense6.56M5.80M5.85M6.87M
OtherGandA6.56M5.80M5.85M6.87M
GrossProfit1.71M1.10M1.40M543.55K
CostOfRevenue3.24M3.50M2.73M545.89K
TotalRevenue4.94M4.60M4.14M1.09M
OperatingRevenue4.94M4.60M4.14M1.09M
Line Item2025-06-302024-06-302023-06-302022-06-30
OrdinarySharesNumber2.00M445.95K166.41K32.53K
ShareIssued2.00M445.95K166.41K32.53K
TotalDebt741.26K962.66K391.71K793.77K
TangibleBookValue11.81M7.42M10.14M6.97M
InvestedCapital13.43M9.21M12.09M9.08M
WorkingCapital11.03M6.72M9.33M6.28M
NetTangibleAssets11.81M7.42M10.14M6.97M
CapitalLeaseObligations741.26K962.66K391.71K793.77K
CommonStockEquity13.43M9.21M12.09M9.08M
TotalCapitalization13.43M9.21M12.09M9.08M
TotalEquityGrossMinorityInterest13.43M9.21M12.09M9.08M
StockholdersEquity13.43M9.21M12.09M9.08M
GainsLossesNotAffectingRetainedEarnings128.57K128.57K128.57K128.57K
OtherEquityAdjustments128.57K128.57K128.57K128.57K
ForeignCurrencyTranslationAdjustments128.57K128.57K
RetainedEarnings-117.24M-109.08M-101.40M-93.45M
AdditionalPaidInCapital39.32M35.37M35.74M31.68M
CapitalStock91.22M82.78M77.62M70.72M
CommonStock91.22M82.78M77.62M70.72M
TotalLiabilitiesNetMinorityInterest2.15M2.62M2.02M3.71M
TotalNonCurrentLiabilitiesNetMinorityInterest305.75K644.87K15.99K389.50K
LongTermDebtAndCapitalLeaseObligation305.75K644.87K15.99K389.50K
LongTermCapitalLeaseObligation305.75K644.87K15.99K389.50K
CurrentLiabilities1.84M1.97M2.00M3.32M
CurrentDeferredLiabilities0.0016.17K0.00
CurrentDebtAndCapitalLeaseObligation435.51K317.80K375.71K404.28K
CurrentCapitalLeaseObligation435.51K317.80K375.71K404.28K
PensionandOtherPostRetirementBenefitPlansCurrent490.40K488.28K542.30K139.12K
PayablesAndAccruedExpenses913.88K1.17M1.07M2.78M
CurrentAccruedExpenses543.74K539.54K522.25K1.11M
Payables370.14K626.19K544.18K1.67M
OtherPayable500.00K
AccountsPayable370.14K626.19K544.18K1.17M
TotalAssets15.58M11.82M14.11M12.79M
TotalNonCurrentAssets2.71M3.13M2.77M3.19M
OtherNonCurrentAssets100.00K100.00K104.91K176.64K
GoodwillAndOtherIntangibleAssets1.62M1.78M1.95M2.11M
OtherIntangibleAssets1.62M1.78M1.95M2.11M
NetPPE992.20K1.25M723.43K904.25K
AccumulatedDepreciation-1.34M-1.36M-925.32K-516.47K
GrossPPE2.33M2.61M1.65M1.42M
Leases40.41K42.99K
OtherProperties2.33M2.56M1.61M1.38M
MachineryFurnitureEquipment0.0040.41K40.41K40.41K
Properties0.000.00
CurrentAssets12.87M8.69M11.33M9.60M
OtherCurrentAssets321.75K477.75K498.03K797.23K
RestrictedCash43.38K43.06K44.42K44.80K
PrepaidAssets797.23K956.76K
Inventory961.17K1.24M1.62M2.49M
FinishedGoods676.18K840.81K893.51K473.43K
WorkInProcess26.70K30.82K514.11K1.72M
RawMaterials258.30K372.69K208.74K292.58K
Receivables465.10K352.84K260.40K88.03K
AccountsReceivable465.10K352.84K260.40K88.03K
AllowanceForDoubtfulAccountsReceivable-2.42K0.00-66.78K
GrossAccountsReceivable467.53K352.84K327.17K
CashCashEquivalentsAndShortTermInvestments11.08M6.57M8.91M6.18M
OtherShortTermInvestments44.80K46.46K
CashAndCashEquivalents11.08M6.57M8.91M6.18M
Line Item2025-06-302024-06-302023-06-302022-06-30
FreeCashFlow-7.77M-7.00M-7.45M-15.62M
RepaymentOfDebt0.00-290.83K0.00
IssuanceOfCapitalStock8.13M5.22M10.68M17.15M
CapitalExpenditure-9.29K-161.80K-39.11K-1.73K
InterestPaidSupplementalData0.000.000.000.00
IncomeTaxPaidSupplementalData0.007.10K13.10K0.00
EndCashPosition11.08M6.57M8.91M6.18M
BeginningCashPosition6.57M8.91M6.18M7.36M
EffectOfExchangeRateChanges0.00494.96K
ChangesInCash4.50M-2.34M2.74M-1.19M
FinancingCashFlow12.27M4.65M10.68M15.07M
CashFlowFromContinuingFinancingActivities12.27M4.65M10.68M15.07M
NetOtherFinancingCharges-883.98K-562.15K-1.32M-1.78M
ProceedsFromStockOptionExercised5.02M175.00646.00
NetCommonStockIssuance8.13M5.22M10.68M17.15M
CommonStockIssuance8.13M5.22M10.68M17.15M
NetIssuancePaymentsOfDebt0.00-290.83K0.00
NetLongTermDebtIssuance0.00-290.83K0.00
LongTermDebtPayments0.00-290.83K0.00
InvestingCashFlow0.00-9.29K-661.80K-673.00K
CashFlowFromContinuingInvestingActivities0.00-9.29K-661.80K-673.00K
NetOtherInvestingChanges-425.00K
NetInvestmentPurchaseAndSale0.000.000.000.00
SaleOfInvestment42.27K42.08K42.27K0.00
PurchaseOfInvestment-42.27K-42.08K-42.27K0.00
NetBusinessPurchaseAndSale0.00-500.00K-208.89K0.00
SaleOfBusiness0.0091.57K0.00
PurchaseOfBusiness0.00-500.00K-300.46K0.00
NetPPEPurchaseAndSale0.00-9.29K-161.80K-39.11K
SaleOfPPE0.00
PurchaseOfPPE0.00-9.29K-161.80K-39.11K
OperatingCashFlow-7.77M-6.99M-7.28M-15.58M
CashFlowFromContinuingOperatingActivities-7.77M-6.99M-7.28M-15.58M
InterestReceivedCFO131.00
ChangeInWorkingCapital-337.17K-369.34K-565.82K-3.07M
ChangeInOtherWorkingCapital-16.17K16.17K-5.14K
ChangeInOtherCurrentLiabilities-429.88K-397.42K-426.57K-341.86K
ChangeInOtherCurrentAssets0.004.91K5.51K-61.43K
ChangeInPayablesAndAccruedExpense-249.73K45.28K-806.53K-811.60K
ChangeInPrepaidAssets173.98K20.28K299.19K190.66K
ChangeInInventory283.15K66.22K565.56K-2.00M
ChangeInReceivables-114.69K-92.44K-219.15K-40.01K
ChangesInAccountReceivables-114.69K-92.44K-219.15K-40.01K
OtherNonCashItems-35.00-1.25K-803.001.39M
StockBasedCompensation119.31K137.71K278.15K697.89K
ProvisionandWriteOffofAssets2.42K0.0046.77K0.00
AssetImpairmentCharge0.00305.81K308.94K3.47M
DepreciationAmortizationDepletion534.73K604.52K596.00K511.79K
DepreciationAndAmortization534.73K604.52K596.00K511.79K
AmortizationCashFlow162.64K171.86K202.25K159.23K
AmortizationOfIntangibles162.64K171.86K202.25K159.23K
Depreciation372.09K432.66K393.75K352.56K
OperatingGainsLosses75.93K12.26K1.18K13.12K
GainLossOnInvestmentSecurities-242.63K
NetForeignCurrencyExchangeGainLoss75.93K12.26K1.18K1.77K
NetIncomeFromContinuingOperations-8.16M-7.68M-7.95M-18.60M
SEC Filings

Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.

Public Trades for INM
Date User Asset Broker Type Position Size Entry Price Patterns